RTA-40 is a synthetic triple GLP-1, GIP, and glucagon receptor agonist peptide currently under extensive investigation for its role in metabolic signalling, energy homeostasis, and receptor pathway modulation. Of significant interest to researchers studying the comparative activity of multi-receptor agonism versus selective GLP-1 compounds in metabolic research models. Each batch is independently third-party verified for identity and purity prior to release.